Aurobindo Pharma's Secretarial Auditor M/s. MRR & Associates resigned effective May 22, 2026 due to health issues of its sole proprietor.
The Board appointed M/s. RPR & Associates as new Secretarial Auditor for a five-year term starting FY 2026-27, subject to shareholder approval.
The Board meeting approving this change was held on May 21, 2026, commencing at 4:30 PM and concluding at 6:25 PM.